Patents by Inventor Alexander Drew

Alexander Drew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180153987
    Abstract: A chimeric fusion polypeptide is provided comprising an extracellular domain of a canine TNF receptor p60 or p80 polypeptide conjoined to an Fc region of a canine IgG immunoglobulin heavy chain. The chimeric fusion polypeptide may be used in the treatment or prevention of conditions in canines mediated by TNF expression.
    Type: Application
    Filed: July 14, 2017
    Publication date: June 7, 2018
    Applicant: NEXVET AUSTRALIA LTD
    Inventors: Alexander DREW, David Gearing
  • Patent number: 9731007
    Abstract: A chimeric fusion polypeptide is provided comprising an extracellular domain of a canine TNF receptor p60 or p80 polypeptide conjoined to an Fc region of a canine IgG immunoglobulin heavy chain. The chimeric fusion polypeptide may be used in the treatment or prevention of conditions in canines mediated by TNF expression.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: August 15, 2017
    Assignee: Nexvet Australia Pty Ltd
    Inventors: Alexander Drew, David Gearing
  • Publication number: 20150037333
    Abstract: A chimeric fusion polypeptide is provided comprising an extracellular domain of a canine TNF receptor p60 or p80 polypeptide conjoined to an Fc region of a canine IgG immunoglobulin heavy chain. The chimeric fusion polypeptide may be used in the treatment or prevention of conditions in canines mediated by TNF expression.
    Type: Application
    Filed: February 22, 2013
    Publication date: February 5, 2015
    Applicant: NVIP Pty Ltd
    Inventors: Alexander Drew, David Gearing